The World Health Organization gave emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution on Tuesday.
The decision “makes the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the (novel coronavirus) outbreak began a year ago,” WHO said in a statement.
Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.
WHO said its emergency use listing opens the way for regulators in different countries to approve the import and distribution of the vaccine.
